Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  BioPorto A/S    BIOPOR   DK0011048619

BIOPORTO A/S (BIOPOR)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsCalendarCompany 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
11/20/2017 11/21/2017 11/22/2017 11/23/2017 11/24/2017 Date
3.58(c) 3.48(c) 3.52(c) 3.49(c) 3.5 Last
86 240 178 915 69 425 92 119 4 077 Volume
+0.28% -2.79% +1.15% -0.85% +0.29% Change
More quotes
Company
Bioporto A/S is an in-vitro diagnostics company which provides healthcare professionals in clinical and research settings, a range of diagnostic tests and antibodies.It provides antibodies within medical specialties such as obesity, diabetes and primary immune deficiency.The company was founded on... 
Sector
Pharmaceuticals
Calendar
03/21Earnings Release
More about the company
Latest news on BIOPORTO A/S
11/10 BIOPORTO A/S : USPTO approves BioPorto’s NGAL Trauma patent for issuance
11/09 BIOPORTO A/S : Share Capital and Votes
11/07 BIOPORTO A/S : Interim report, third quarter of 2017
11/03 BIOPORTO A/S : Managers’ transactions
11/03 BIOPORTO A/S : Completion of share capital increase
11/02 BIOPORTO A/S : Private placement fully subscribed
10/27 BIOPORTO A/S : increases the share capital through a cash issue, private placeme..
10/27 BIOPORTO A/S INCREASES THE SHARE CAP : Not for release, publication or distribut..
08/10 BIOPORTO A/S : Correction to announcement no 11 - Managers’ transactions
08/10 BIOPORTO A/S : Managers’ transactions
More news
Sector news : Diagnostic & Testing Substances Manufacturers
09:31aDJBAYER : Amikacin Inhale Fails to Meet Objectives in Phase 3 Trial
11/23 German chemicals companies should review British ops - trade body
11/23DJGLAXOSMITHKLINE : Files Additional Trelegy Ellipta Application to FDA
11/22 BAYER : Brazil pushes back decision on Bayer-Monsanto tie-up
11/22 European shares retreat on euro bounce; UK flat after budget
More sector news : Diagnostic & Testing Substances Manufacturers
Chart BIOPORTO A/S
Duration : Period :
BioPorto A/S Technical Analysis Chart | BIOPOR | DK0011048619 | 4-Traders
Technical analysis trends BIOPORTO A/S
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Managers
NameTitle
Peter Mørch Eriksen Chief Executive Officer
Thomas Magnussen Chairman
Jan Kuhlmann Andersen Chief Operating Officer
Jakob Brix Christensen Chief Financial Officer
Torben A. Nielsen Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
BIOPORTO A/S66.19%0
JOHNSON & JOHNSON19.17%368 832
NOVARTIS12.82%219 874
ROCHE HOLDING LTD.6.15%215 394
PFIZER9.08%211 188
ABBVIE50.86%150 594